AI pathology accelerates with Proscia Concentriq launch
Proscia, an AI-enabled pathology solutions software company, has announced the launch of Concentriq Embeddings and the Proscia AI Toolkit, hoping to accelerate precision medicine R&D.
Concentriq Embeddings delivers a collection of pathology foundation models to AI developers and researchers for routine workflows, leveraging Proscia’s large proprietary datasets.
During pilot programmes, Concentriq Embeddings demonstrated its ability to significantly accelerate AI development. In one internal case study, data scientists developed algorithms 13x faster, generating 80 AI-based breast cancer biomarker prediction models in under 24 hours.
Proscia’s CEO, David West, said: “It’s an exciting time at the intersection of medicine and technology. The proliferation of digital pathology and explosion in capabilities of today’s AI models bring a totally new scale to how to develop therapies and diagnose patients.”
“We’re approaching a world where experiments that once took years can now be run in silico in a matter of days, and life-saving treatments that reach only a fraction of patients today could soon reach everyone,” he continued.
Enabled within Proscia’s Concentriq platform, Concentriq Embeddings allows pathology and data science teams to generate high-dimensional numerical representations – or “embeddings” – from whole slide images. These are initially derived from four powerful foundation models (DINOv2, PLIP, ConvNext, and CTransPath), with plans to continuously add new models as they evolve.
Researchers can also select the best foundation model for their specific needs, with applications ranging from image classification and segmentation to risk scoring and multimodal data integration, supporting rapid prototyping and large-scale AI model development directly within the Concentriq platform.
The platform is further enriched by Proscia’s real-world data (RWD) offering, providing access to high-quality, diverse multimodal datasets that empower researchers to build more accurate and clinically viable AI models.
To complement Concentriq Embeddings, Proscia is also introducing the Proscia AI Toolkit, a suite of open-source resources designed to empower the life sciences community and accelerate AI adoption.
Julianna Ianni, VP of AI research & development at Proscia, commented: “This is truly powerful technology. Concentriq Embeddings […] will spark a new wave of innovation in pathology […] setting the stage for transformative advancements in both research and patient care.”
AI – Beyond hype
AI is certainly advancing apace. And upcoming health innovation conference Frontiers Health, taking place in Berlin 17th and 18th October, will be hosting a number of AI sessions, moving beyond AI hype into concrete examples of artificial intelligence in action and thoughtful discussion of the technology’s actual potential for creating meaningful change in the healthcare industry.
